Get started
Author

William Erne

ORCID: 0000-0001-7305-4884
Observed ORCID: 0000-0001-7305-4884
OpenAlex ID: A5045003814
Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma
2020 · Caroline Spenlé, Thomas Loustau, et al. · Cancer Immunology Research · 83
PDF
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
2021 · Devadarssen Murdamoothoo, Zhen Sun, et al. · EMBO Molecular Medicine · 72
PDF
Tenascin-C increases lung metastasis by impacting blood vessel invasions
2019 · Zhen Sun, Inés Velázquez-Quesada, et al. · Matrix Biology · 72
PDF
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
2020 · Claire Deligne, Devadarssen Murdamoothoo, et al. · Cancer Immunology Research · 69
PDF
Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies
2021 · Sayda Dhaouadi, Rahma Ben Abderrazek, et al. · Frontiers in Immunology · 23
PDF
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, “MAREMO”
2022 · Thomas Loustau, Chérine Abou-Faycal, et al. · Matrix Biology · 13
PDF
Dicer1 deficient mice exhibit premature aging and metabolic perturbations in adipocytes
2022 · Aurore De Cauwer, Thomas Loustau, et al. · iScience · 12
PDF
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity
2024 · Chengbei Li, Amanpreet Kaur, et al. · Proceedings of the National Academy of Sciences · 10
Generation and characterization of dromedary Tenascin-C and Tenascin-W specific antibodies
2020 · Sayda Dhaouadi, Devadarssen Murdamoothoo, et al. · Biochemical and Biophysical Research Communications · 9
Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
2023 · Claire Deligne, Devadarssen Murdamoothoo, et al.
Supplementary Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
2023 · Claire Deligne, Devadarssen Murdamoothoo, et al.
Supplementary Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
2023 · Claire Deligne, Devadarssen Murdamoothoo, et al.
PDF
Data from Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma
2023 · Caroline Spenlé, Thomas Loustau, et al.
Supplementary Data from Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma
2023 · Caroline Spenlé, Thomas Loustau, et al.
PDF
Modulation of the effects of TRAIL by the extracellular matrix in cancer and development of new Tenascin-C-targeting peptides
2020 · William Erne · theses.fr (ABES)
Works count: 15
Citation count: 363
H-index: 9
I10-index: 8
Year
Topic
Type